ReAct UHC Intervention at UNGA Multi-stakeholder Hearing for High-level Meeting on UHC 29 April 2019 in New York
Thank you chair, ReAct – Action on Antibiotic Resistance is grateful for the opportunity to speak today.
No health system will be sustainable without effectively working antibiotics. Access to many of the miracles of modern day medicine – from cancer chemotherapy to organ transplant and everyday surgeries like C-sections – would no longer be safely available. The cost of healthcare would increase, with increased morbidity, mortality and extended hospitalization costs. We therefore ask that availability and affordability of effective antibiotics be made an integral part of the package of universal healthcare. Planning pooled, public sector procurement and government-coordinated production can help ensure healthcare systems reliably supply effective antibiotics, diagnostics and vaccines.
Antimicrobial Resistance should become a substantive part of the work on UHC and needs a measurable accountability mechanism. The World Bank projects that 24.1 million people could fall into extreme poverty by 2030 because of antimicrobial resistance. Most of these people would come from low- and middle-income countries falling into poverty. The WHO called antimicrobial resistance one of the Top 10 threats to Global Health in 2019. Yet the SDGs and the WHO/World Bank UHC Monitoring mechanism do not take into account Antimicrobial Resistance sufficiently.
More news and opinion
- Four key points from joint comments to One Health Global Leaders Group on AMR
- Why are children more vulnerable to AMR?
- Dr Yoel Lubell, Health Economist, on Thailand, AMR, UCH and cultural factors driving AMR
- UHC and AMR: The Thai Experience
- Why do effective antibiotics matter for quality of care and patient safety?
- New ReAct policy brief: Antimicrobial resistance and universal health coverage – What’s the deal?
- Three key takeaways from the ReAct Africa conference
- Diagnostics: Species identification
- AMR-specific indicator proposed for monitoring Sustainable Development Goals
- Five focus areas at the 2nd Ministerial Conference on AMR hosted by the Netherlands
- Safety concerns of fecal microbiota transplants
- Upcoming ReAct Africa Conference: universal health coverage and antimicrobial resistance in focus
- Mother Earth conference in Argentina – the environment in focus
- Diagnostics: What are we talking about?
- Connecting global to local civil-society-agenda on AMR at CSO convening in Geneva
- ReAct colleagues featured in WHO Bulletin as leading profiles in the work on reacting to antibiotic resistance
- RAN stakeholder at WHO IPC consultation – for standards and guidelines in African Union member states
- WHA conversation on Antibiotic Resistance as a Global Development Problem co-organized by ReAct
- 8 insights from ReAct Asia Pacific project on antibiotic stewardship in secondary level hospitals in India
- Open letter to UN Member States from former IACG members Anthony So and Otto Cars
- ReAct UHC Intervention at UNGA Multi-stakeholder Hearing for High-level Meeting on UHC
- ReAct Latin America honors Earth Day
- Medicines Patent Pool’s view on the role of licenses for antibiotics – World Intellectual Property Day
- Second time for Innovate4AMR competition!
- World Health Day 2019: Universal Health Coverage
- Diagnostics: Constraints for successful implementation
- Antibiotic Shortages: magnitude, causes and possible solutions: A new WHO meeting report
- Erry Setyawan, FAO, on Indonesian NAP: We need to work together to make it possible to manage AMR
- ReAct’s new 5-year strategic plan receives funding from Sida
- How infections spread and how to stop them
- Generating data for policy and practice